HCW Biologics HCWB Cash Flow Statement (2020-2026)

NASDAQ HCWB
$1.16 -0.01 (-0.85%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

HCW Biologics Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

HCW Biologics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 24 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-2.75M-4.09M-3.17M-2.06M-3.51M-3.91M-5.42M-5.07M-4.30M-4.94M-10.68M-7.47M-15.28M-3.90M-3.37M-2.20M-1.93M-4.55M0.72M-5.22M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.15M0.12M0.11M0.14M0.15M0.16M0.26M0.30M0.28M0.28M0.27M0.24M0.13M0.13M0.68M0.42M0.29M0.17M0.16M
Share-based CompensationStock Comp.
0.00M0.35M0.26M0.27M0.30M0.29M0.26M0.26M0.22M0.26M0.24M0.24M0.23M0.29M0.28M0.28M0.21M0.01M
Gains from Investment SecuritiesGains Investment
-0.07M-0.19M-0.02M-0.04M0.07M0.11M0.11M0.03M
Other non-cash itemsOther Non-Cash
-1.13M-1.00-5.33M-0.48M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.25M0.02M0.06M0.42M-0.21M0.01M0.06M-0.16M0.45M0.00M0.83M-0.63M-0.25M0.00M-0.07M-0.49M-0.07M0.01M0.00M
Change in Accured ExpensesChange Accured Exp.
0.76M0.49M-0.07M-1.07M-0.28M1.14M0.62M0.72M0.49M-0.82M1.23M2.50M9.40M0.49M-0.51M-2.40M-0.37M-0.36M-0.34M
Change in Other Operating AssetsOther Assets Change
0.71M1.62M0.62M-1.38M-0.48M0.01M-0.63M-0.18M0.23M0.20M-0.68M-0.30M-0.40M-0.13M0.00M0.26M-0.26M-0.16M0.02M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M-0.04M-0.04M-0.04M-0.08M-0.08M-0.08M-0.08M-0.06M
Other Working Capital ChangesOther WC Changes
-0.71M-1.62M-0.62M1.37M0.45M-0.05M0.59M0.10M-0.31M-0.28M0.60M0.25M0.40M0.13M0.00M-0.26M0.26M0.16M-0.02M
Cash from OperationsCash from Ops.
-0.99M-5.12M-3.38M-1.59M-2.69M-2.31M-3.79M-3.64M-9.39M-5.59M-3.89M-3.60M-4.86M-2.93M-2.83M-3.51M-3.28M-3.24M-3.36M
Investing Activities
Capital ExpendituresCapex
0.00M0.02M0.02M0.01M10.17M0.07M0.30M1.56M0.63M3.72M0.13M-0.02M0.04M0.11M
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.02M-0.02M-0.01M-10.17M-0.07M-0.30M-1.56M-0.63M-3.72M-0.13M0.02M-0.04M-0.11M
Purchase of InvestmentsInvestments Purchased
34.97M0.00M8.00M-8.00M
Sale and Maturity of InvestmentsInvestments Sold
8.00M16.98M10.00M
Cash from Investing ActivitiesCash from Investing
-34.97M-0.02M7.98M-0.01M6.81M-0.07M-0.30M-1.56M9.37M-3.72M-0.13M0.02M-0.04M-0.11M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.75M1.95M2.83M0.38M0.15M
Non-Current Debt
1.75M1.95M2.83M0.38M0.15M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M56.00M0.01M0.00M0.01M0.00M0.01M0.00M0.01M84.000.01M2.50M6.92M0.00M5.30M4.02M
Net Shares Issued and RepurchasedNet Shares Issued
0.01M56.00M0.01M0.00M0.01M0.00M0.01M0.00M0.01M84.000.01M2.50M6.92M0.00M5.30M4.02M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.01M56.00M0.01M0.00M0.01M0.00M0.01M0.00M0.01M84.000.01M2.50M6.92M0.00M5.30M4.02M
Other financing activitiesOther financing
-0.82M0.92M-0.14M-0.05M-0.64M-0.02M-0.80M-0.06M-0.32M
Cash from Financing ActivitiesCash from Financing
-0.81M-48.36M98.53M0.00M0.01M6.30M-0.04M0.00M0.01M-0.01M-0.02M4.22M1.92M2.80M6.62M-0.05M4.61M1.90M4.21M
Additional items
Change in Cash
-1.81M10.07M-3.39M6.39M-2.70M10.80M-3.90M-3.94M-10.94M3.77M-7.63M0.49M-2.92M-0.16M3.68M-3.57M1.33M-1.34M0.86M
Ending Cash Balance
5.05M15.13M11.73M18.12M15.42M26.22M22.33M18.39M7.45M11.22M3.60M4.08M1.16M1.00M4.67M1.11M2.44M1.10M1.95M0.74M
Free Cash FlowFCF
-0.99M-5.12M-3.40M-1.62M-2.70M-12.48M-3.86M-3.94M-10.95M-6.22M-7.61M-3.73M-4.84M-2.96M-2.95M-3.51M-3.28M-3.24M-3.36M
Net Cash FlowNCF
-1.81M-88.45M95.13M6.39M-2.70M10.80M-3.90M-3.94M-10.94M3.77M-7.63M0.49M-2.92M-0.16M3.68M-3.57M1.33M-1.34M0.86M
Interest Paid
0.13M0.09M0.10M0.10M0.00M0.16M0.18M0.23M0.24M0.16M0.09M0.11M

HCW Biologics Cash Flow Statement API

Pull HCW Biologics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HCWB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY